Medium materiality6/10
Ovid Therapeutics initiated with an Outperform at Wolfe Research
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: Wolfe Research initiates OVID with Outperform. Target $5; Posted price $2.19.
- Target: $5; Posted price: $2.19; Firm: Wolfe Research
Key facts
- 01
Target: $5
- 02
Posted price: $2.19
- 03
Analyst firm: Wolfe Research
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.